Rick Thompson retweeted
We’ve compiled a series of case studies to demystify the #DrugRepurposing process. Our latest case features Nitroxoline, a common antibiotic repurposed for rare amoebic encephalitis—led by #iDR25 speaker Natasha Spottiswoode.
➡️ More here: loom.ly/g4avr9o
Rick Thompson retweeted
And just like that, #OpenAcademy2024 is complete! 🎉
Our thanks go to everyone who has made this experience possible and our amazing group of participants for throwing themselves into the training so wholeheartedly!
Learn more about #EURORDISOpenAcademy: openacademy.eurordis.org
It was an absolute privilege to be part of the team organising and delivering #iDR24. Thanks to all the attendees, and my amazing colleagues in @RareBeacon and @REMEDi4ALL!
See you next year!
🌟Thanks for joining us at the #iDR24 International #DrugRepurposing Conference in Barcelona.
We look forward to our next opportunity to meet, discuss the many challenges, bust myths, share best practices & further work towards a better future for patients.
Safe journey home.
Rick Thompson retweeted
Wow - what a great day innovating, connecting & reshaping the #DrugRepurposing ecosystem! We'd love to hear your takeaways from the day.
📣And it's not over yet...the #iDR24 poster presentations are about to take place!
Rick Thompson retweeted
⚡The air is electric here on Day 1 at #iDR24! Together with over 50 speakers from across a broad range of disciplines we will deep-dive into the evolving landscape of #DrugRepurposing.
➡️Find out more here: remedi4all.org/international…
The winner of this years @RDStudentVoice prize has been published by @ojrarediseases . Check out the fantastic essay on “Embracing the Unknown” by Leisha Devisetti this #RareDiseaseDay2024
ojrd.biomedcentral.com/artic…
I’ve been writing about the VITAL role of #patients in #RareDisease research this #RareDiseaseDay2024 - how do you see patients driving research change?
This quoted post is unavailable.
Prof Alfredo Budillon introduces the VESPA trial - one of the demonstrator projects within @REMEDi4ALL looking to repurpose drugs for pancreatic cancer.
Dr Luca Cardone says repurposing is a mandatory strategy for #PancreaticCancer research the the @REMEDi4ALL Multistakeholder meeting.
Ali Stunt, founder of @OfficialPCA Pancreatic Cancer Action in the UK, talks about her personal pancreatic cancer story and the need for improved outcomes for patients.
Patrycja shares her personal story as a pancreatic cancer survivor - investigative tests found a tumour in her abdomen at the age of 25.
Don Lo from @REMEDi4ALL makes the case for repurposing - why find every possible new drug out there before we have made the BEST use of the drugs we already have?
Gauthier Bouche from the @Anticancerfund takes us into the world of repurposing at the @REMEDi4ALL multistakeholder meeting.
We’re off! Prof Alfredo Carrara gives the opening talk for the first @REMEDi4ALL multistakeholder meeting. We’re talking pancreatic cancer and repurposing.
Really happy to be at the @AMRC festival of partnerships today. Learning a lot, and highlighting our work for #rarediseases at @RareBeacon
Rick Thompson retweeted
@REMEDi4ALL, patients are equal partners in research. 🔬
Rick Thompson (@RickSThomp), CEO @RareBeacon and project partner shares his views on why #patientengagement matters so much.
👉 Find out more about @REMEDi4ALL here: remedi4all.org
Ready to kick off the 1st
@REMEDi4ALL Sustainability meeting! Feeling strategic?
Rick Thompson retweeted
Do you want to work with us? 🙋
With openings across all three of our European offices, we are looking for talented and passionate individuals to join the EURORDIS team. If you believe in our vision and mission then we want to hear from you!
🔗 go.eurordis.org/wvv7f7
























